The trading price of Fractyl Health Inc. (NASDAQ:GUTS) floating lower at last check on Monday, April 01, closing at $6.42, -13.24% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $14.50 and a 52-week low of $5.92. Over the past month, the stock has lost -28.67% in value.
Fractyl Health Inc., whose market valuation is $305.66 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.33 per share this quarter, however they have predicted annual earnings per share of -$1.51 for 2024 and -$1.89 for 2025. It means analysts are expecting annual earnings per share growth of -25.20% next year.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Fractyl Health Inc. No upward and no downward comments were posted in the last 7 days.
A quick review shows that GUTS’s price is currently -17.30% off the SMA20 and -23.74% off the SMA50. The RSI metric on the 14-day chart is currently showing 33.13, and weekly volatility stands at 10.98%. When measured over the past 30 days, the indicator reaches 11.87%. Fractyl Health Inc. (NASDAQ:GUTS)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 1.00.
To see how Fractyl Health Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: GUTS stock’s performance was -13.24% in the latest trading.
An evaluation of the daily trading volume of Fractyl Health Inc. (NASDAQ:GUTS) indicates that the 3-month average is 482.64K. However, this figure has increased over the past 10 days to an average of 0.24 million.
Currently, records show that 47.61 million of the company’s shares remain outstanding. The insiders hold 53.25% of outstanding shares, whereas institutions hold 3.90%. The stats also highlight that short interest as of Mar 15, 2024, stood at 3.43 million shares, resulting in a short ratio of 6.72 at that time. From this, we can conclude that short interest is 7.21% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 1.03 million. However, since the stock’s price has seen -50.04% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
